APA (7th ed.) Citation

Elnaghi, K. A. E. A., Alghanmi, H. A., Elsamany, S. A., Almarzoki, F., Elsafty, M., & Jaffal, M. Hormonal-Receptors-Positive and HER2-Negative Patients with Metastatic Breast Cancer Treated with First-Line Palbociclib and Hormonal Therapy: Impact of First-Cycle Neutropenia and Dose Reduction on Therapeutic Outcome. Wiley.

Chicago Style (17th ed.) Citation

Elnaghi, Khaled Abd Elaziz Ahmed, Hosam Ali Alghanmi, Shereef Ahmed Elsamany, Fathia Almarzoki, Mohamed Elsafty, and Mohammad Jaffal. Hormonal-Receptors-Positive and HER2-Negative Patients with Metastatic Breast Cancer Treated with First-Line Palbociclib and Hormonal Therapy: Impact of First-Cycle Neutropenia and Dose Reduction on Therapeutic Outcome. Wiley.

MLA (9th ed.) Citation

Elnaghi, Khaled Abd Elaziz Ahmed, et al. Hormonal-Receptors-Positive and HER2-Negative Patients with Metastatic Breast Cancer Treated with First-Line Palbociclib and Hormonal Therapy: Impact of First-Cycle Neutropenia and Dose Reduction on Therapeutic Outcome. Wiley.